Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia
Katherine Beck, Guy Hindley, Faith Borgan, et al.
JAMA Network Open (2020) Vol. 3, Iss. 5, pp. e204693-e204693
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Schizophrenia
Sameer Jauhar, Mandy Johnstone, Peter J. McKenna
The Lancet (2022) Vol. 399, Iss. 10323, pp. 473-486
Open Access | Times Cited: 547
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1902-1918
Open Access | Times Cited: 305
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver Howes, Ekaterina Shatalina
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 501-513
Open Access | Times Cited: 152
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 49
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments
Stephen R. Marder, Daniel Umbricht
Schizophrenia Research (2023) Vol. 258, pp. 71-77
Open Access | Times Cited: 42
Neurotransmitter function
Mitul A. Mehta, Peter C.T. Hawkins
Elsevier eBooks (2024), pp. 136-151
Closed Access | Times Cited: 42
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 15
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
Chiara Gastaldon, Emanuel Raschi, John M. Kane, et al.
Psychotherapy and Psychosomatics (2020) Vol. 90, Iss. 1, pp. 41-48
Closed Access | Times Cited: 93
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 69
Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
Glutamatergic dysfunction in Schizophrenia
Andreas O. Kruse, Juan Bustillo
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission
Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 86-97
Open Access | Times Cited: 12
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology
Robert A. McCutcheon, Lilian Weber, Matthew M. Nour, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 554-565
Closed Access | Times Cited: 10
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction
Neha S. Rawani, Allen W. Chan, Serdar Dursun, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 709-709
Open Access | Times Cited: 10
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Gamma oscillations and excitation/inhibition imbalance: parallel effects of N-methyl D-aspartate receptor antagonism and psychosis
Brian J. Roach, Judith M. Ford, Spero Nicholas, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2025)
Open Access | Times Cited: 1
Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective
Bianca Bianciardi, Peter J. Uhlhaas
Neuroscience & Biobehavioral Reviews (2021) Vol. 124, pp. 308-323
Open Access | Times Cited: 42
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis
Haley Maria Dourron, Camilla K. Strauss, Peter S. Hendricks
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 984-1029
Open Access | Times Cited: 23
Neurofunctional correlates of glutamate and GABA imbalance in psychosis: A systematic review
Uzma Zahid, Ellis Chika Onwordi, Emily Hedges, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 105010-105010
Open Access | Times Cited: 23
CCPNet136: automated detection of schizophrenia using carbon chain pattern and iterative TQWT technique with EEG signals
Mehmet Bayğın, Prabal Datta Barua, Subrata Chakraborty, et al.
Physiological Measurement (2023) Vol. 44, Iss. 3, pp. 035008-035008
Closed Access | Times Cited: 15
Regulation of the E/I-balance by the neural matrisome
Cornelius Mueller-Buehl, David Wegrzyn, Juliane Bauch, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top